These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 24816687

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X, Li G.
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [Abstract] [Full Text] [Related]

  • 3. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.
    Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, Zhao L, Qu H, Fan Y, Wu C.
    PLoS One; 2012; 7(6):e39520. PubMed ID: 22761812
    [Abstract] [Full Text] [Related]

  • 4. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
    Zhang Y, Zhao FJ, Chen LL, Wang LQ, Nephew KP, Wu YL, Zhang S.
    Oncotarget; 2014 Dec 15; 5(23):12291-303. PubMed ID: 25460499
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y, Dun Y, Zhou S, Huang XH.
    Biomed Pharmacother; 2017 Dec 15; 96():1216-1221. PubMed ID: 29239819
    [Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH, Xiong F, Wang JP, Li JH, Zhong M, Liu QL, Luo GQ, Yang XJ, Xiao N, Xie B, Xiao H, Liu RJ, Dong CS, Wang KS, Wen JF.
    PLoS One; 2014 Dec 15; 9(6):e99922. PubMed ID: 24945379
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C, Xie Y, Zhuang X, Yuan Z.
    Biomed Pharmacother; 2018 Aug 15; 104():763-770. PubMed ID: 29807226
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.
    Cao Y, Shi H, Ren F, Jia Y, Zhang R.
    Exp Cell Res; 2017 Oct 01; 359(1):185-194. PubMed ID: 28754469
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H, Ding Y, Yang X.
    Biomed Res Int; 2021 Oct 01; 2021():6619730. PubMed ID: 34250088
    [Abstract] [Full Text] [Related]

  • 13. IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway.
    Guo QY, Song JN, Chen YM, Yuan HN, Xue WS, Sun Y, Niu XL, Wang Y, Chen X.
    Med Oncol; 2024 May 14; 41(6):155. PubMed ID: 38744773
    [Abstract] [Full Text] [Related]

  • 14. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH, Yang J, Gao LK, Min J, Tang JM, Hu M, Li Y, Li ST, Chen J, Hong L.
    Oncol Rep; 2019 Feb 14; 41(2):917-927. PubMed ID: 30483796
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
    Li F, Liang A, Lv Y, Liu G, Jiang A, Liu P.
    Med Sci Monit; 2017 Oct 28; 23():5139-5149. PubMed ID: 29080395
    [Abstract] [Full Text] [Related]

  • 16. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ, Lin S, Liu JN, Zhang MB, Du YT, Zhang DD, Xu WH, Wang HB.
    J Cell Physiol; 2019 Aug 28; 234(10):18587-18601. PubMed ID: 30953349
    [Abstract] [Full Text] [Related]

  • 17. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.
    Sun Y, Hu L, Zheng H, Bagnoli M, Guo Y, Rupaimoole R, Rodriguez-Aguayo C, Lopez-Berestein G, Ji P, Chen K, Sood AK, Mezzanzanica D, Liu J, Sun B, Zhang W.
    J Pathol; 2015 Jan 28; 235(1):25-36. PubMed ID: 25230372
    [Abstract] [Full Text] [Related]

  • 18. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C, Li Y, Zhao W, Liu G, Yang Q.
    Cancer Med; 2020 May 28; 9(10):3500-3521. PubMed ID: 32167655
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA‑320 targets mitogen‑activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer.
    Xu Y, Hu J, Zhang C, Liu Y.
    Mol Med Rep; 2017 Dec 28; 16(6):8530-8536. PubMed ID: 28990044
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
    Ying X, Wei K, Lin Z, Cui Y, Ding J, Chen Y, Xu B.
    Cell Physiol Biochem; 2016 Dec 28; 39(2):501-10. PubMed ID: 27383536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.